President Donald Trump took on Big Pharma Monday with an executive order that will reduce the prices for prescriptions. The

President Trump signed the executive order shortly before 11 a.m. after a press conference in which he and top officials railed against the drug industry and painted the order as

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

On May 12th the president signed an executive order that seeks to force drugmakers to reduce their prices in America to align with the lowest rate they charge in other rich countries. That adds to the consternation of pharma bosses already fretting over Mr Trump’s protectionism.

The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit organizations to push industry talking points in Washington and across the nation.

Trump’s previous attempt to implement international reference pricing during his first term was blocked in court, though it was estimated to save over $85 billion over seven years by reducing the U.S.